Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving Chemotherapy


FİDAN S., FİDAN E., Alandag C., ERKUT M., COŞAR A. M.

ARCHIVES OF IRANIAN MEDICINE, vol.23, no.12, pp.835-841, 2020 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 23 Issue: 12
  • Publication Date: 2020
  • Doi Number: 10.34172/aim.2020.111
  • Journal Name: ARCHIVES OF IRANIAN MEDICINE
  • Journal Indexes: Science Citation Index Expanded, Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, Index Islamicus, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.835-841

Abstract

Background: Reactivation of the hepatitis B virus (HBV) either during or after chemotherapy may cause serious and sometimes fatal hepatitis. All patients undergoing chemotherapy should therefore be screened in terms of HBV before chemotherapy. The purpose of this research was to identify HBV screening rates in patients with solid cancer undergoing parenteral chemotherapy and to determine the outcomes of patients undergoing HBV screening.